◀ Back to PARP1

FOS — PARP1

Text-mined interactions from Literome

Martin-Oliva et al., Cancer Res 2006 (Cell Transformation, Neoplastic...) : Inhibition of PARP also affected activator protein-1 (AP-1) activation but not nuclear factor-kappaB (NF-kappaB)
García et al., Ann Rheum Dis 2008 (Arthritis, Rheumatoid) : PARP inhibition reduced TNF induced JNK phosphorylation and AP-1 and NF kappaB binding activities were partially impaired by treatment with PARP inhibitors or by PARP-1 knockdown
Pacurari et al., Environ Health Perspect 2008 (Neoplasms, Mesothelial) : In the present study, we exposed mesothelial cells to SWCNTs and investigated reactive oxygen species ( ROS ) generation, cell viability, DNA damage, histone H2AX phosphorylation, activation of poly(ADP-ribose) polymerase 1 ( PARP-1 ), stimulation of extracellular signal regulated kinase ( ERKs ), Jun N-terminal kinases (JNKs), protein p38, and activation of activator protein-1 (AP-1) , nuclear factor kappaB (NF-kappaB), and protein serine-threonine kinase ( Akt )